查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
北美医药合约销售组织市场预测至 2030 年 - 区域分析 - 按服务、模组、治疗领域和最终用户
市场调查报告书
商品编码
1494468

北美医药合约销售组织市场预测至 2030 年 - 区域分析 - 按服务、模组、治疗领域和最终用户

North America Pharmaceutical Contract Sales Organizations Market Forecast to 2030 - Regional Analysis - by Services, Modules, Therapeutic Area, and End User
出版日期: | 出版商: The Insight Partners | 英文 86 Pages | 订单完成后即时交付

价格

北美药品合约销售组织市场预计将从2022年的39.8729亿美元成长到2030年的76.1412亿美元。

数位技术的日益整合推动北美药品合约销售组织市场

数位技术的增加部署推动了药品合约销售组织 (CSO) 市场的转型浪潮。这项根本性变化凸显了对动态变化的医药市场采取战术反应的必要性。简化销售营运、提高生产力以及应对日益数位化的医疗保健环境的复杂性的一个重要组成部分是将数位工具和技术整合到 CSO 中。借助先进的客户关係管理工具、人工智慧和资料分析，CSO 可以获得宝贵的见解、客製化销售策略并与医疗保健专业人员建立更深层的关係。除了加快资讯传输之外，数位平台的无缝整合还可以即时适应市场趋势和立法变化。製药 CSO 领域的这种技术变革不仅仅是一种时尚，而是一种时尚。它代表了对销售策略的製定和实施方式的根本性重新定义。数位技术的采用使公民社会组织处于创新的前沿。它促进了一个更具回应性的环境，与席捲医疗保健产业的更大的数位转型一致。随着製药 CSO 继续利用数位化的力量，在技术专业知识、战略敏捷性和对製药生态系统当代需求的清晰认识的推动下，市场将实现持续增长。

北美药品合约销售组织市场概况

北美的药品合约销售组织市场分为美国、加拿大和墨西哥。 2022年，美国在该地区占据最大市场份额，预计在预测期内将继续保持主导地位。由于合约销售组织采用新技术、製药公司日益重视促进小分子和生物製药药物的销售以及对切割的关注度增加，北美的药品合约销售组织市场预计将增长。合约销售组织市场成长的主要因素。随着时间的推移，新药的上市数量激增。根据 IQVIA 的研发趋势报告，2021 年全球推出了 84 种新活性化合物，是前 5 年推出数量的两倍。随着国际药物发布的增加，预计对合约销售服务的需求将会增加。北美占据药品合约销售组织市场的最大份额。 EPS Corp. 等主要参与者； IQVIA 公司；和 Axxelus 为该地区的市场提供了动力。

北美药品合约销售组织市场收入及 2030 年预测（百万美元）

北美药品合约销售组织市场细分

北美药品合约销售组织市场分为服务、模组、治疗领域、最终用户和国家。

根据服务，北美药品合约销售组织市场分为商业服务和非商业服务。 2022年，商业服务领域在北美药品合约销售组织市场中占据更大份额。

根据模组，北美药品合约销售组织市场分为联合模组和专用模组。 2022 年，联合模组细分市场在北美药品合约销售组织市场中占据更大份额。

根据治疗领域，北美药品合约销售组织市场分为心血管疾病、肿瘤、代谢性疾病、神经病学、骨科疾病、传染病等。 2022 年，肿瘤学领域在北美药品合约销售组织市场中占据最大份额。

根据最终用户，北美药品合约销售组织市场分为生物製药公司和製药公司。 2022 年，製药公司细分市场在北美药品合约销售组织市场中占据更大份额。

根据国家/地区，北美药品合约销售组织市场分为美国、加拿大和墨西哥。 2022年，美国在北美药品合约销售组织市场占据主导地位。

Aenova Holding GmbH、Axxelus Inc、CMIC Holdings Co Ltd、IQVIA Holdings Inc、Peak Pharma Solutions Inc、Pfizer Inc、Promoveo Health LLC、QFR Solutions LLC、Sales Focus Inc 和 Syneos Health Inc 是在北方运营的一些领先公司美国药品合约销售组织市场。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美药品合约销售组织市场格局

  • 概述
  • PEST分析
    • 北美 PEST 分析

第 5 章：北美药品合约销售组织市场 - 主要产业动态

  • 主要市场驱动因素
    • 数位科技的不断融合
    • 製药公司对增加产品销售的兴趣日益浓厚
  • 主要市场限制
    • 与外包相关的品质问题
  • 主要市场机会
    • 远距医疗和远距细节的使用不断增加
  • 未来主要趋势
    • 新兴市场的扩张
  • 影响分析：

第 6 章： 药品合约销售组织市场 - 北美市场分析

  • 北美药品合约销售组织市场收入，2022 - 2030

第 7 章：北美药品合约销售组织市场 - 收入和 2030 年预测 - 按服务

  • 概述
  • 2022 年及 2030 年北美药品合约销售组织市场收入份额（按服务划分）（%）
  • 商业服务
  • 非商业服务

第 8 章：北美药品合约销售组织市场 - 收入和 2030 年预测 - 按模组

  • 概述
  • 北美药品合约销售组织市场收入份额，按模组 2022 年和 2030 年 (%)
  • 联合模组
  • 专用模组

第 9 章：北美药品合约销售组织市场 - 收入和 2030 年预测 - 按治疗领域

  • 概述
  • 2022 年和 2030 年北美药品合约销售组织市场收入份额（按治疗领域）（%）
  • 心血管疾病
  • 肿瘤学
  • 代谢紊乱
  • 神经病学
  • 骨科疾病
  • 传染性疾病
  • 其他的

第 10 章：北美药品合约销售组织市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年及 2030 年北美药品合约销售组织市场收入份额（按最终用户划分）（%）
  • 生物製药公司
  • 製药公司

第 11 章：北美药品合约销售组织市场 - 国家分析

  • 北美洲
      • 北美药品合约销售组织市场（按国家/地区）
      • 我们
      • 加拿大
      • 墨西哥

第 12 章：药品合约销售组织市场 - 产业格局

  • 概述
  • 成长策略
    • 概述

第 13 章：公司简介

  • CMIC Holdings Co Ltd
  • Axxelus Inc
  • IQVIA Holdings Inc
  • Peak Pharma Solutions Inc
  • QFR Solutions LLC
  • Promoveo Health LLC
  • Syneos Health Inc
  • Aenova Holding GmbH
  • Pfizer Inc
  • Sales Focus Inc

第 14 章：附录

Product Code: BMIRE00030017

The North America pharmaceutical contract sales organizations market is expected to grow from US$ 3,987.29 million in 2022 to US$ 7,614.12 million by 2030. It is estimated to record a CAGR of 8.4% from 2022 to 2030.

Increasing Integration of Digital Technologies Drives North America Pharmaceutical Contract Sales Organizations Market

The increased deployment of digital technologies fuels a transformational surge in the pharmaceutical contract sales organization (CSO) market. This fundamental change highlights the need for a tactical response to the dynamically changing pharmaceutical market. An essential component of streamlining sales operations, increasing productivity, and navigating the complexities of a healthcare environment that is becoming increasingly digitized is integrating digital tools and technologies into CSOs. With advanced customer relationship management tools, artificial intelligence, and data analytics, CSOs can gain valuable insights, customize their sales strategies, and establish deeper relationships with healthcare professionals. In addition to speeding up information transmission, the seamless integration of digital platforms allows for real-time adaptability to market trends and legislative changes. This technological change in the pharmaceutical CSO landscape represents more than just a fad; it represents a fundamental redefining of how sales tactics are developed and implemented. The adoption of digital technologies places CSOs at the forefront of innovation. It promotes a more responsive environment that aligns with the larger digital transformation sweeping the healthcare sector. The market is positioned for sustained growth as pharmaceutical CSOs continue to use the power of digitalization, propelled by a convergence of technological expertise, strategic agility, and a clear awareness of the contemporary demands of the pharmaceutical ecosystem.

North America Pharmaceutical Contract Sales Organizations Market Overview

The pharmaceutical contract sales organizations market in North America is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during the forecast period. The pharmaceutical contract sales organizations market in North America is expected to grow due to the adoption of new technologies by contract sales organizations, the surging emphasis of pharmaceutical companies in boosting the sales of small-molecule and biopharmaceutical drugs, and an increase in focus on cutting down the costs incurred by in-house sales operations are the major factors driving the growth of the pharmaceutical contract sales organizations market in North America. The number of launches of new medicine has spiked over time. According to a report by IQVIA on R&D trends, 84 new active compounds were introduced globally in 2021, twice as many as introduced in the previous 5 years. The demand for contract sales services is anticipated to rise with the increase in drug releases internationally. North America accounts for the largest share of the pharmaceutical contract sales organization market. Key players such as EPS Corp.; IQVIA, Inc.; and Axxelus fuel the market in this region.

North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Million)

North America Pharmaceutical Contract Sales Organizations Market Segmentation

The North America pharmaceutical contract sales organizations market is segmented into services, modules, therapeutic area, end user, and country.

Based on services, the North America pharmaceutical contract sales organizations market is bifurcated into commercial services and non-commercial services. The commercial services segment held a larger share of the North America pharmaceutical contract sales organizations market in 2022.

Based on modules, the North America pharmaceutical contract sales organizations market is bifurcated into syndicated modules and dedicated modules. The syndicated modules segment held a larger share of the North America pharmaceutical contract sales organizations market in 2022.

Based on therapeutic area, the North America pharmaceutical contract sales organizations market is segmented into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment held the largest share of the North America pharmaceutical contract sales organizations market in 2022.

Based on end user, the North America pharmaceutical contract sales organizations market is bifurcated into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held a larger share of the North America pharmaceutical contract sales organizations market in 2022.

Based on country, the North America pharmaceutical contract sales organizations market is segmented into the US, Canada, and Mexico. The US dominated the North America pharmaceutical contract sales organizations market in 2022.

Aenova Holding GmbH, Axxelus Inc, CMIC Holdings Co Ltd, IQVIA Holdings Inc, Peak Pharma Solutions Inc, Pfizer Inc, Promoveo Health LLC, QFR Solutions LLC, Sales Focus Inc, and Syneos Health Inc are some of the leading companies operating in the North America pharmaceutical contract sales organizations market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Pharmaceutical Contract Sales Organizations Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis

5. North America Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Integration of Digital Technologies
    • 5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
  • 5.2 Key Market Restraints
    • 5.2.1 Quality Issues Associated with Outsourcing
  • 5.3 Key Market Opportunities
    • 5.3.1 Rising Use of Telemedicine and Remote Detailing
  • 5.4 Key Future Trends
    • 5.4.1 Expansion in Emerging Markets
  • 5.5 Impact Analysis:

6. Pharmaceutical Contract Sales Organizations Market - North America Market Analysis

  • 6.1 North America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

7. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services

  • 7.1 Overview
  • 7.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
  • 7.3 Commercial Services
    • 7.3.1 Overview
    • 7.3.2 Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Non-Commercial Services
    • 7.4.1 Overview
    • 7.4.2 Non-Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules

  • 8.1 Overview
  • 8.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
  • 8.3 Syndicated Modules
    • 8.3.1 Overview
    • 8.3.2 Syndicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Dedicated Modules
    • 8.4.1 Overview
    • 8.4.2 Dedicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area

  • 9.1 Overview
  • 9.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
  • 9.3 Cardiovascular Disorders
    • 9.3.1 Overview
    • 9.3.2 Cardiovascular Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Oncology
    • 9.4.1 Overview
    • 9.4.2 Oncology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Metabolic Disorders
    • 9.5.1 Overview
    • 9.5.2 Metabolic Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Neurology
    • 9.6.1 Overview
    • 9.6.2 Neurology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.7 Orthopaedic Diseases
    • 9.7.1 Overview
    • 9.7.2 Orthopedic Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.8 Infectious Diseases
    • 9.8.1 Overview
    • 9.8.2 Infectious Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.9 Others
    • 9.9.1 Overview
    • 9.9.2 Others: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
  • 10.3 Biopharmaceutical Companies
    • 10.3.1 Overview
    • 10.3.2 Biopharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Pharmaceutical Companies
    • 10.4.1 Overview
    • 10.4.2 Pharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Pharmaceutical Contract Sales Organizations Market - Country Analysis

  • 11.1 North America
      • 11.1.1.1 North America Pharmaceutical Contract Sales Organizations Market, by Country
      • 11.1.1.2 US
        • 11.1.1.2.1 US: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.2.2 US: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.2.3 US: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.2.4 US: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.2.5 US: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.3 Canada
        • 11.1.1.3.1 Canada: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.3.2 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.3.3 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.3.4 Canada: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.3.5 Canada: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
      • 11.1.1.4 Mexico
        • 11.1.1.4.1 Mexico: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.4.2 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
        • 11.1.1.4.3 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
        • 11.1.1.4.4 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
        • 11.1.1.4.5 Mexico: North America Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)

12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies
    • 12.2.1 Overview

13. Company Profiles

  • 13.1 CMIC Holdings Co Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Axxelus Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 IQVIA Holdings Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Peak Pharma Solutions Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 QFR Solutions LLC
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Promoveo Health LLC
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Syneos Health Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Aenova Holding GmbH
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Pfizer Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Sales Focus Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Pharmaceutical Contract Sales Organizations Market Segmentation
  • Table 2. US: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. US: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Canada: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Canada: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico: North America Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
  • Table 15. Glossary of Terms, North America Pharmaceutical Contract Sales Organizations Market

List Of Figures

  • Figure 1. North America Pharmaceutical Contract Sales Organizations Market Segmentation, By Country
  • Figure 2. North America - PEST Analysis
  • Figure 3. North America Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
  • Figure 7. Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Non-Commercial Services: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
  • Figure 10. Syndicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Dedicated Modules: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
  • Figure 13. Cardiovascular Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Oncology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Metabolic Disorders: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Neurology: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Orthopedic Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Infectious Diseases: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. North America Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 21. Biopharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Pharmaceutical Companies: North America Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. North America Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 24. North America Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)
  • Figure 25. US: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Canada: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Mexico: North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)